Nursing Therapeutics Education and Heart Failure (HF): a Study Protocol (NEHF)
Nursing Therapeutics Education and Heart Failure (HF): an Experimental Study
Sponsor: University of Rome Tor Vergata
Terminated
Feasability phase completed: Cost Evaluation
This NA trial investigates Arrhythmia and Heart Failure and is currently terminated or withdrawn. University of Rome Tor Vergata leads this study, which shows 6 recorded versions since 2015 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
Status: Suspended → Terminated
-
Nov 2017 — Jun 2018 [monthly]
Suspended NA
Status: Recruiting → Suspended
▶ Show 1 earlier version
-
Jan 2017 — Nov 2017 [monthly]
Recruiting NA
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Rome Tor Vergata
- University of Turin, Italy
For direct contact, visit the study record on ClinicalTrials.gov .